NRG1 and stroke disorder: Astragaloside VI (2 μg/kg, 100 nM) miligated post-stroke depression by increasing DA and 5-HT release through upregulation of the MEK/ERK pathway mediated by the neurotrophic factor neuregulin 1 (NRG-1) (Chen et al., 2022b).